Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial - Chakravarthy, U; Harding, S P; Rogers, C AIVAN Study Investigators (Ophthalmology, 2012)
et al.